Phase 1 Clinical Trials2018-09-04T23:05:13+00:00

Phase 1 Clinical Trials

Clinilabs Drug Development Corporation provides full range of CNS Phase I capabilities, with extensive experience in early phase studies required for regulatory approval. We offer expertise that provides a sound foundation for all Phase I projects.

  • First in human

  • First in class

  • Single ascending dose (SAD)

  • Multiple ascending dose (MAD)

  • Bioequivalence (BE)

  • Drug – drug interaction studies

  • Drug – alcohol interactions studies

  • Food effect studies

  • Pharmacokinetic (PK) studies

  • Pharmacodynamic (PD) studies

  • Kinetic-dynamic relationships

All truths are easy to understand once they are discovered; the point is to discover them.

– Galileo Galilei